Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
74.88
+1.38 (1.88%)
At close: Sep 12, 2025

SHA:688192 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Cash & Equivalents
1,245250.1674.2121.67364.24509.02
Upgrade
Trading Asset Securities
1,006589.836741,2951,71190.29
Upgrade
Cash & Short-Term Investments
2,251839.99748.21,4162,075599.31
Upgrade
Cash Growth
171.85%12.27%-47.18%-31.74%246.26%173.25%
Upgrade
Accounts Receivable
82.1427.4948.44-7.556.9
Upgrade
Other Receivables
3.34-----
Upgrade
Receivables
85.4827.4948.44-7.556.9
Upgrade
Inventory
40.5544.1123.475.07--
Upgrade
Other Current Assets
28.1987.3790.6551.6429.5718.86
Upgrade
Total Current Assets
2,405998.97910.361,4732,112625.07
Upgrade
Property, Plant & Equipment
342.81243.91102.26103.66104.4815.19
Upgrade
Other Intangible Assets
412.98429.85461.98492.02474.9506.25
Upgrade
Long-Term Deferred Charges
5.068.6216.997.994.543.53
Upgrade
Other Long-Term Assets
52.6837.384.795.0649.5131.98
Upgrade
Total Assets
3,2181,7191,4962,0822,7461,182
Upgrade
Accounts Payable
18.7620.3918.578.811.651.06
Upgrade
Accrued Expenses
280.87245.07182.18208.53182.7594.26
Upgrade
Short-Term Debt
359.94373.83200.11---
Upgrade
Current Portion of Long-Term Debt
110.9641.270.1---
Upgrade
Current Portion of Leases
19.6923.5322.9521.3416.84-
Upgrade
Current Income Taxes Payable
--0.050-0.01
Upgrade
Current Unearned Revenue
7.682.930.98---
Upgrade
Other Current Liabilities
90.378.0623.499.8210.767.79
Upgrade
Total Current Liabilities
888.2785.08448.44248.49211.99103.11
Upgrade
Long-Term Debt
660.81683.76138.31---
Upgrade
Long-Term Leases
26.5434.9948.8963.9370.92-
Upgrade
Long-Term Unearned Revenue
14.1314.8412.1111--
Upgrade
Total Liabilities
1,5901,519647.75323.43282.91103.11
Upgrade
Common Stock
459.41417.65408.15407.16404.18360
Upgrade
Additional Paid-In Capital
4,9023,1362,9542,7572,729718.88
Upgrade
Retained Earnings
-3,737-3,360-2,514-1,406-669.850.03
Upgrade
Total Common Equity
1,624193.76848.631,7582,4631,079
Upgrade
Minority Interest
4.626.3----
Upgrade
Shareholders' Equity
1,629200.06848.631,7582,4631,079
Upgrade
Total Liabilities & Equity
3,2181,7191,4962,0822,7461,182
Upgrade
Total Debt
1,1781,157410.3785.2787.76-
Upgrade
Net Cash (Debt)
1,073-317.39337.831,3311,987599.31
Upgrade
Net Cash Growth
656.96%--74.62%-33.02%231.62%173.25%
Upgrade
Net Cash Per Share
2.53-0.770.833.295.521.67
Upgrade
Filing Date Shares Outstanding
459.41417.65408.15407.16404.18360
Upgrade
Total Common Shares Outstanding
459.41417.65408.15407.16404.18360
Upgrade
Working Capital
1,517213.89461.931,2251,900521.97
Upgrade
Book Value Per Share
3.540.462.084.326.093.00
Upgrade
Tangible Book Value
1,211-236.09386.651,2661,988572.66
Upgrade
Tangible Book Value Per Share
2.64-0.570.953.114.921.59
Upgrade
Machinery
57.0255.4349.1431.9926.9123.59
Upgrade
Construction In Progress
283.31169.7213.358.855.040.15
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.